Abstract
Obsessive-compulsive disorder (OCD) is a common condition in children and adolescents, affecting, at a minimum, 1 in 200 teenagers.1 The affected individuals are plagued by intrusive obsessive thoughts, and their lives are disrupted by irresistible compulsions. The clinical presentation of childhood-onset OCD is similar to that of adult-onset OCD, and more than one third of adults suffering from OCD report onset of their symptoms during childhood or adolescence.2 The pre- and post-treatment biochemical profiles and response to pharmacotherapy, particularly treatment with clomipramine, are also similar between adults and children,3 suggesting that information gained from adult studies can be extrapolated to apply to childhood-onset OCD. This is of particular importance because of the limitations on research investigations in patients under 18 years of age. This chapter presents relevant information from both patient groups, adults and children, in order to examine the neuropathology of childhood OCD more fully.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Flament MF, Whitaker A, Rapoport JL, et al : Obsessive compulsive disorder in adolescence: An epidemiologic study. J Am Acad Child Adolesc Psychiatry 27:764–771, 1988
Rapoport JL : Annotation: Childhood obsessive compulsive disorder. J Child Psychol Psychiatry 27:289–296, 1986
Flament MF, Rapoport JL, Berg CJ, et al : Clomipramine treatment of childhood obsessive compulsive disorder: A double-blind controlled study. Arch Gen Psychiatry 42:977–983, 1986
Leonard HL, Rapoport JL : Drug treatment of children and adolescents with obsessive compulsive disorder, in Rapoport JL (ed): Obsessive Compulsive Disorder in Children and Adolescents. Washington, D.C., American Psychiatric Press, 1989, pp 217–236
Insel TR, Murphy DL, Cohen RM et al : Obsessive compulsive disorder: A double blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 40:605–612, 1983
Volavka J, Neziroglu F, Yaryura-Tobias JA : Clomipramine and imipramine in obsessive compulsive disorder. Psychiatry Res 14:83–91, 1985
Insel TR, Mueller EA, Alterman I, et al : Obsessive compulsive disorder and serotonin. Is there a connection? Biol Psychiatry 20:1174–1188, 1985
Yaryura-Tobias JA, Neziroglu F, Bergman L : Clomipramine for obsessive compulsive neurosis: An organic approach. Curr Ther Res 20:541–548, 1976
Thoren P, Asberg M, Cronholm B, et al : Clomipramine treatment of obsessive compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 37:1281–1285, 1980
Marks M, Stem RS, Mawsen D, et al : Clomipramine and exposure for obsessive compulsive rituals. Br J Psychiatry 136:1–25, 1980
Montgomery SA : Clomipramine in obsessional neurosis: A placebo controlled trial. Pharm Med 1:189–192, 1980
Ananth J, Pecknold JC, VanDenSteen, et al : Double blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol 5:257–262, 1981
Mavissakalian M, Turner SM, Michelson L, et al : Tricyclic antidepressant in obsessive compulsive disorder: Antiobsessional or antidepressant agents? II. Am J Psychiatry 142;572-576, 1985
Leonard HL, Swedo S, Rapoport JL, et al : Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: A double blind crossover comparison. Psychopharm Bull 24:93–95, 1988
Perse TL, Greist JH, Jefferson JW, et al : Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry 144:1543–1548, 1987
Price LH, Goodman WK, Chamey DS, et al : Treatment of severe obsessive compulsive disorder with fluvoxamine. Am J Psychiatry 144:1059–1061, 1987
Prasad A : A double blind study of imipramine versus zimelidine in treatment of obsessive compulsive neurosis. Pharmacopsychiatry 17:61–62, 1984
Fontaine R, Chouinard G : An open clinical trial of fluoxetine in the treatment of obsessive compulsive disorder. J Clin Psychopharmacol 6:98–101, 1980
Turner SM, Jacob RG, Beidel DC, et al : Fluoxetine treatment of obsessive compulsive disorder. J Clin Psychopharmacol 5:207–212, 1985
Flament MF, Rapoport JL, Murphy DL : Biochemical changes during clomipramine treatment of childhood obsessive compulsive disorder. Arch Gen Psychiatry 44:219–225, 1987
Agren H, Potter WZ, Nordin C : Antidepressant drug action and CSF monoamine metabolites: New evidence for selective profiles on monoaminergic interactions. Presented at theSixth Catecholamine Symposium, Jerusalem, 1987
Murphy DL, Siever JL, Insel TR : Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry 9:9–13, 1985
Zohar J, Insel TR, Zohar-Kadouch RC, et al : Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic chlomipramine treatment. Arch Gen Psychiatry 45:167–172, 1983
Chamey DS, Goodman WK, Price LH et al : Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177–185, 1988
Frankel M, Cummings JL, Robertson MM, et al : Obsessions and compulsions in Gilles de la Tourette’s syndrome. Neurology (NY) 36:378–382, 1986
Sharp T, et al : A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 401:322–330, 1987
Cummings JL, Frankel M : Gilles de la Tourette syndrome and neurological basis of obsessions and compulsions. Biol Psychiatry 20:117–1126, 1985
Pauls DL, Leckman JF, Towbin KE, et al : A possible genetic relationship exists between Tourette’s syndrome and obsessive-compulsive disorder. Psychopharm Bull 22:730–733, 1986
Pauls DL, Leckman JF : The inheritance of Gilles de la Tourette’s syndrome and associated behaviors: Evidence for autosomal dominant transmission. N Engl J Med 315;993–997, 1986
Koizumi HM: Obsessive-compulsive symptoms following stimulants. (Letter.) Biol Psychiatry 20:1332–1333, 1985
Frye P, Arnold L : Persistent amphetamine-induced compulsive rituals: Response to pyridoxine (B6). Biol Psychiatry 16:583–587, 1981
Swedo S : Rituals and releasers: An ethological model of OCD, in Rapoport JL (ed): Obsessive Compulsive Disorder in Children and Adolescents. Washington, D.C., American Psychiatric Press, 1989, pp 269–288
Casas M, Alvarez E, Duro P, et al : Antiandrogenic treatment of obsessive-compulsive neurosis. Acta Psychiatr Scand 73:221–222, 1986
Hamburger SD, Swedo SE, Rapoport JL et al : Growth rate in adolescents with obsessive-compulsive disorder. Am J Psychiatry 146:652–655, 1989
Schletter RE, Clift GV, Meyer R, et al : Cushing’s syndrome in childhood: Report of two cases with bilateral adrenocortical hyperplasia, showing distinctive clinical features. J Clin Endocrinol 27:22–28, 1967
Gispen WH, Isaacson RL : ACTH-induced excessive grooming in the rat. Pharmacol Ther 12:209–240, 1981
Dunn AJ, Green EJ, Isaacson RL : Intracerebral adrenocorticotropic hormone mediates novelty-induced grooming in the rat. Science 203:281–283, 1979
von Economos C: Encephalitis lethargic, its sequelae and treatment. Oxford University Press, 1931. Translated from Economo: die encephalitis lethargica Deuticke, Vienna 1917-1918 and L’encefalik lethargica Policlinica, Rome 1920
Husby G, vandeRyn I, Zabriskie JB, et al : Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and rheumatic fever. J Exp Med 144:1094–1110, 1976
Chapman AH, Pilkey L, Gibbons MJ : A psychosomatic study of eight children with Sydenham’s chorea. Pediatrics 21:582–595, 1958
Freeman JH, Aron AM, Collard JE, et al : The emotional correlates of Sydenham’s chorea. Pediatrics 35:42–49, 1965
Swedo SE, Rapoport JL, Cheslow DL, et al : High prevalence of obsessive compulsive symptoms in patients with Sydenham’s chorea. Am J Psychiatry 146:246–249, 1989
Laplane D, Baulac M, Widlocher D, et al : Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurology Neurosurg Psychiatry 47:377–385, 1984
Luxenburg JS, Swedo SE, Flament MF, et al : Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry 145:1089–1093, 1988
Baxter LR, Phelps ME, Mazziotta JC, et al : Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 44:211–218, 1987
Baxter LR, Schwartz JM, Mazziotta JC, et al : Cerebral glucose metabolic rates in non-depressed obsessivecompulsives. Am J Psychiatry 145:1560–1563, 1988
Swedo SE, Schapiro ME, Grady CL et al : Cerebral glucose metabolism in childhood-onset obsessive compulsive disorder. Arch Gen Psychiat 46:518–523, 1989
Wise SP, Rapoport JL : Obsessive-compulsive disorders: Is it basal ganglia dysfunction? in Rapoport JL (ed), Obsessive Compulsive Disorder in Children and Adolescents. Washington, D.C., American Psychiatric Press, 1989, pp 327–346
Alexander G, DeLong M, Strick KP : Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381, 1981
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Publishing Corporation
About this chapter
Cite this chapter
Swedo, S.E., Rapoport, J.L. (1990). Neurochemical and Neuroendocrine Considerations of Obsessive-Compulsive Disorders in Childhood. In: Deutsch, S.I., Weizman, A., Weizman, R. (eds) Application of Basic Neuroscience to Child Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0525-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0525-5_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7849-8
Online ISBN: 978-1-4613-0525-5
eBook Packages: Springer Book Archive